Get the Latest Investment Ideas Delivered Straight to Your Inbox. Subscribe


Exciting Biotech Stock Now Breaking Out of Large Base
Contributed Opinion

Share on Stocktwits


Technical analyst Clive Maund takes a look at a biotech stock that he views as a strong buy.

3D Signatures Inc. (DXD:TSX.V; TDSGF:OTCQB; 3D0:FSE) is an exciting biotech company that now appears to be getting its act together fast, which is reflected in the recent action in its stock, although it is certainly not too late to buy the stock, otherwise we wouldn't be interested in it. With respect to the fundamentals it is liked here by AlphaNorth Capital's Steve Palmer for the reasons stated briefly in his recent article looking at three Small Caps that he favors.

We'll now see what the charts have to say about it. On an 18-month log chart we can see all of the action in the stock since its inception, and the log chart has the advantage that it opens out the recent base pattern that has just completed, so that we can examine clearly what has been going on. As we can see, the severe decline through most of last year led into a fine large Head-and-Shoulders bottom formation that it started to break out of only a week ago. It didn't hold a clear breakout and has dipped back to support at the upper boundary of the base pattern. This of course was partly due to the broad stock market diving, but as far as its chart is concerned it was due to a still challenging moving average alignment—we have yet to see a cross of the moving averages and the 200-day is still falling steeply—basically it needs a little more time, which is why it reacted back. Additional bullish points to observe on this chart are the high volume on the breakout move—the highest for about 10 months—which is bullish, the now climbing Accum-Distrib line, also positive and the improving momentum that has swung from negative to positive.

The 3-month chart is valuable here as it enables us to see recent action in much more detail. Observe first the heavy volume when it broke out of the Head-and-Shoulders bottom about a week ago, which is bullish, and it is thanks to the broad market drop and still challenging moving average alignment, as mentioned above, that it has dropped back to what is considered to be a good entry point, given that we missed the opportunity to buy it near to the Right Shoulder low of the H&S pattern. Two factors that we can see to advantage on this chart that strongly suggest that it will turn higher from here are that it has reacted back to support at the January highs and the upper boundary of the entire base pattern, and also that volume has shrunk back to a very low level as it has reacted back, suggesting that there are few sellers at lower prices, because holders do not want to sell, for good reason. It could react back a little further but it is considered more likely that it will advance from here.

Conclusion: 3D Signatures is viewed as a strong buy here for a resumption of its advance to complete its breakout from its large Head-and-Shoulders bottom pattern, which should usher in a major bull market advance in this stock. The company's stock trades in rather light volumes on the US OTC market, which are expected to improve as it advances.

3D Signatures website

3D Signatures Inc, DXD.V, TDSGF on OTC, closed at C$0.33, $0.252 on 2nd March 2018.

Clive Maund has been president of, a successful resource sector website, since its inception in 2003. He has 30 years' experience in technical analysis and has worked for banks, commodity brokers and stockbrokers in the City of London. He holds a Diploma in Technical Analysis from the UK Society of Technical Analysts.

Want to read more Life Sciences Report articles like this? Sign up for our free e-newsletter, and you'll learn when new articles have been published. To see recent articles and interviews with industry analysts and commentators, visit our Streetwise Interviews page.

1) Clive Maund: I, or members of my immediate household or family, own shares of the following companies mentioned in this article: None. I personally am, or members of my immediate household or family are, paid by the following companies mentioned in this article: None. My company has a financial relationship with the following companies mentioned in this article: None. disclosures below. I determined which companies would be included in this article based on my research and understanding of the sector.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: 3D Signatures. Click here for important disclosures about sponsor fees.
3) Statements and opinions expressed are the opinions of the author and not of Streetwise Reports or its officers. The author is wholly responsible for the validity of the statements. The author was not paid by Streetwise Reports for this article. Streetwise Reports was not paid by the author to publish or syndicate this article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
4) This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article, until one week after the publication of the interview or article. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of 3D Signatures, a company mentioned in this article.

Charts provided by the author. Disclosure:
The above represents the opinion and analysis of Mr Maund, based on data available to him, at the time of writing. Mr. Maund's opinions are his own, and are not a recommendation or an offer to buy or sell securities. Mr. Maund is an independent analyst who receives no compensation of any kind from any groups, individuals or corporations mentioned in his reports. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stock market analyst, Clive Maund is not a Registered Securities Advisor. Therefore Mr. Maund's opinions on the market and stocks can only be construed as a solicitation to buy and sell securities when they are subject to the prior approval and endorsement of a Registered Securities Advisor operating in accordance with the appropriate regulations in your area of jurisdiction.

Want to read more about Life Sciences Tools & Diagnostics investment ideas?
Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe